Latest On ImmunoGen, Inc (IMGN):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-13 00:43 EST | News | ImmunoGen: Making A Successful Comeback | N/A |  |
| 2023-05-10 03:48 EST | News | 2 Regulatory Submissions Of ELAHERE In 2023 Make ImmunoGen A Must Watch | N/A | |
| 2023-05-05 15:04 EST | News | ImmunoGen prices $325M offering | N/A | |
| 2023-05-04 13:06 EST | News | ImmunoGen's Elahere Breakthrough Offers Hope For Patients And Investors Alike | N/A | |
| 2023-05-04 13:05 EST | News | ImmunoGen: Shares Take Flight On Ovarian Cancer Survival Data - What Happens Next? | N/A | |
| 2023-05-04 00:44 EST | News | ImmunoGen crosses $2B market cap as Piper upgrades on Elahere data | N/A | |
| 2023-05-04 00:44 EST | News | ImmunoGen proposes $200M stock offering | N/A | |
| 2023-05-04 00:44 EST | News | Hot Stocks: SPT, MRCY drop on earnings news; SMCI surges; IMGN jumps 130%+ on clinical data | N/A | |
| 2023-05-04 00:44 EST | News | Why did ImmunoGen stock rocket today? Ovarian cancer drug data | N/A | |
| 2023-05-03 11:44 EST | News | ImmunoGen surges ~95% as ovarian cancer drug Elahere shows survival benefit in confirmatory trial | N/A | |
| 2023-05-03 11:44 EST | News | Sutro, Mersana jump after Immunogen data for ovarian cancer therapy | N/A | |
| 2023-04-28 20:31 EST | News | ImmunoGen surges 22% on Q1 earnings beat | N/A | |
| 2023-04-28 20:31 EST | News | ImmunoGen, Inc. (IMGN) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-04-28 20:31 EST | News | Mersana jumps 18% on rival ImmunoGen's ovarian cancer treatment sales | N/A | |
| 2023-04-28 07:46 EST | News | ImmunoGen GAAP EPS of -$0.16 beats by $0.09, revenue of $49.87M | N/A | |
| 2023-04-27 19:36 EST | News | ImmunoGen Q1 2023 Earnings Preview | N/A | |
| 2023-04-06 14:57 EST | News | ImmunoGen signs up for up to $175M loan | N/A | |
| 2023-03-01 12:13 EST | News | ImmunoGen beats Q4 top and bottom line estimates; initiates FY23 outlook | N/A | |
| 2023-03-01 12:13 EST | News | Vertex in pact with ImmunoGen to expand gene editing reach | N/A | |
| 2023-03-01 12:12 EST | News | ImmunoGen, Inc. (IMGN) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-28 21:23 EST | News | ImmunoGen Q4 2022 Earnings Preview | N/A | |
| 2023-02-14 23:11 EST | News | Maverick Capital exits Intel, Carvana in Q4; adds Catalent, CBRE | N/A | |
| 2023-02-14 09:52 EST | News | ImmunoGen: Despite First Approval, They Have Many Problems | N/A | |
| 2022-12-29 04:34 EST | News | ImmunoGen ends losing streak as William Blair cites cancer guidance | N/A | |
| 2022-12-29 04:33 EST | News | ImmunoGen names Renee Lentini interim CFO as Susan Altschuller on medical leave | N/A | |
| 2022-12-13 07:26 EST | News | ImmunoGen, Biosion team up to create antibody-drug conjugates for cancer | N/A | |
| 2022-12-09 19:54 EST | News | ImmunoGen stock rises on team up with Gilead for blood cancer study | N/A | |
| 2022-11-30 18:54 EST | News | ImmunoGen Needs To Make The Most Of Its First-Mover Opportunity | N/A | |
| 2022-11-24 07:22 EST | News | ImmunoGen: Elucidating Ramifications Of The Elahere Approval | N/A | |
| 2022-11-22 03:25 EST | News | ImmunoGen, Mersana win buy ratings at Truist on ADC prospects | N/A | |
| 2022-11-15 20:23 EST | News | Roche's Ventana test gets FDA approval for use with ovarian cancer drug Elahere | N/A | |
| 2022-11-15 20:23 EST | News | ImmunoGen drops 11% amid plans to launch $6K cancer drug | N/A | |
| 2022-11-15 03:29 EST | News | ImmunoGen wins FDA approval of antibody-drug conjugate Elahere for ovarian cancer | N/A | |
| 2022-11-04 21:17 EST | News | ImmunoGen reports Q3 mixed earnings; raises FY22 revenue guidance | N/A | |
| 2022-11-04 21:17 EST | News | ImmunoGen, Inc. (IMGN) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-04 03:58 EST | News | ImmunoGen Q3 2022 Earnings Preview | N/A | |
| 2022-10-27 09:51 EST | News | ImmunoGen Before The PDUFA | N/A | |
| 2022-08-31 14:33 EST | News | ImmunoGen expects topline readout for blood cancer drug in 2024 after FDA feedback | N/A | |
| 2022-08-17 02:45 EST | News | ImmunoGen: Mirvetuximab Decision Expected For November | N/A | |
| 2022-07-29 14:23 EST | News | ImmunoGen GAAP EPS of -$0.24 misses by $0.03, revenue of $14.2M misses by $1.98M, reiterates FY guidance | N/A | |
| 2022-07-29 14:23 EST | News | ImmunoGen stock down 7% on disappointing Q2 result | N/A | |
| 2022-07-29 14:23 EST | News | ImmunoGen, Inc. (IMGN) CEO Mark Enyedy on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-07-29 00:47 EST | News | ImmunoGen Q2 Earnings Preview | N/A | |
| 2022-06-21 09:25 EST | News | ImmunoGen: Possible Accelerated FDA Approval For Ovarian Cancer Treatment | N/A | |
| 2022-05-24 20:08 EST | News | ImmunoGen (IMGN) Investor Presentation - Slideshow | N/A | |
| 2022-05-23 22:01 EST | News | ImmunoGen ovarian cancer therapy undergoes FDA priority review | N/A | |
| 2022-05-18 08:24 EST | News | ImmunoGen: An Inflection Point In Growth | N/A | |
| 2022-05-07 03:23 EST | News | ImmunoGen GAAP EPS of -$0.10 beats by $0.11, revenue of $38.08M beats by $17.24M | N/A | |
| 2022-05-07 03:23 EST | News | ImmunoGen, Inc. (IMGN) CEO Mark Enyedy on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-06 03:57 EST | News | ImmunoGen Q1 2022 Earnings Preview | N/A | |
About ImmunoGen, Inc (IMGN):
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and IMGN632, a CD123-targeting ADC that is in Phase I clinical trial for treating AML and blastic plasmacytoid dendritic cell neoplasm. Its preclinical program include IMGC936, an investigational ADC in co-development with MacroGenics, Inc. ImmunoGen, Inc. has collaborations with Roche; Amgen/Oxford BioTherapeutics; sanofi-aventis U. S. LLC; Biotest AG; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Takeda Pharmaceutical Company Limited; Fusion Pharmaceuticals Inc.; Debiopharm International SA; Jazz Pharmaceuticals Ireland Limited; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.
General
- Name ImmunoGen, Inc
- Symbol IMGN
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 79
- Fiscal Year EndDecember
- IPO Date1989-11-16
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.immunogen.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 11.65
- Price/Book (Most Recent Quarter) 19.51
- Enterprise Value Revenue 11.17
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.77
- Next Year EPS Estimate -$0.78
- Next Quarter EPS Estimate -$0.19
- Profit Margin -34%
- Operating Margin -16%
- Return on Assets -4%
- Return on Equity -660%
- Revenue 132.3 million
- Earnings Per Share -$1.19
- Revenue Per Share $0.75
- Gross Profit 17.71 million
- Quarterly Earnings Growth 91.2%
View More
Highlights
- Market Capitalization 1.65 billion
- EBITDA -142690000
- Analyst Target Price $10.21
- Book Value Per Share $0.46
View More
Share Statistics
- Shares Outstanding 199.73 million
- Shares Float 169.83 million
- % Held by Insiders 54%
- % Held by Institutions 73.63%
- Shares Short 22.89 million
- Shares Short Prior Month 26.63 million
- Short Ratio 7.14
- Short % of Float 13%
- Short % of Shares Outstanding 11%
View More
Technicals
- Beta 1.45
- 52 Week High $10.88
- 52 Week Low $2.26
- 50 Day Moving Average 8.54
- 200 Day Moving Average 6.36
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
ImmunoGen, Inc (IMGN) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
ImmunoGen, Inc (IMGN) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-12 | $N/A | $0.16 | -$0.08 | 297.29% |
| 2020-09-30 | 2020-11-06 | $N/A | -$0.13 | -$0.19 | 29.73% |
| 2020-06-30 | 2020-07-31 | $N/A | -$0.14 | -$0.17 | 17.11% |
| 2020-03-31 | 2020-05-01 | $N/A | -$0.17 | -$0.15 | -10.89% |
| 2019-12-31 | 2020-02-14 | $44.86 million | $0.03 | -$0.05 | 163.03% |
| 2019-09-30 | 2019-11-01 | $13.28 million | -$0.15 | -$0.18 | 16.53% |
| 2019-06-30 | 2019-08-02 | $15.54 million | -$0.29 | -$0.33 | 11.75% |
| 2019-03-31 | 2019-05-03 | $8.58 million | -$0.30 | -$0.30 | 1.12% |
| 2018-12-31 | 2019-02-08 | $13.42 million | -$0.28 | -$0.32 | 11.76% |
| 2018-09-30 | 2018-11-02 | $10.93 million | -$0.32 | -$0.33 | 2.68% |
| 2018-06-30 | 2018-07-27 | $9.29 million | -$0.31 | -$0.29 | -8.58% |
| 2018-03-31 | 2018-05-04 | $19.82 million | -$0.30 | -$0.28 | -8.58% |
| 2017-12-31 | 2018-02-09 | $39.45 million | -$0.11 | -$0.12 | 11.58% |
| 2017-09-30 | 2017-11-03 | $8.48 million | -$0.61 | -$0.28 | -121.74% |
| 2017-06-30 | 2017-07-28 | $39.02 million | -$0.10 | -$0.16 | 39.32% |
| 2017-03-31 | 2017-05-05 | $28.5 million | -$0.20 | -$0.37 | 45.76% |
| 2016-12-31 | 2017-02-17 | $13.85 million | -$0.39 | -$0.38 | -2.63% |
| 2016-09-30 | 2016-10-28 | $7.66 million | -$0.51 | -$0.38 | -34.21% |
| 2016-06-30 | 2016-08-04 | $7.41 million | -$0.51 | -$0.39 | -31.17% |
| 2016-03-31 | 2016-04-29 | $19.71 million | -$0.37 | -$0.31 | -20.25% |
| 2015-12-31 | 2016-01-29 | $18.03 million | -$0.38 | -$0.36 | -4.74% |
| 2015-09-30 | 2015-10-27 | $14.85 million | -$0.39 | -$0.35 | -11.43% |
| 2015-06-30 | 2015-07-31 | $12.61 million | -$0.35 | -$0.35 | 0% |
| 2015-03-31 | 2015-04-24 | $11.43 million | -$0.25 | -$0.24 | -4.17% |
| 2014-12-31 | 2015-01-30 | $48.3 million | $0.16 | -$0.05 | 420% |
| 2014-09-30 | 2014-10-24 | $13.2 million | -$0.26 | -$0.15 | -73.33% |
| 2014-06-30 | 2014-08-01 | $5.74 million | -$0.31 | -$0.32 | 3.13% |
| 2014-03-31 | 2014-04-25 | $6.88 million | -$0.44 | -$0.27 | -62.96% |
| 2013-12-31 | 2014-01-31 | $30.06 million | $0.04 | -$0.18 | 122.22% |
| 2013-09-30 | 2013-10-25 | $17.22 million | -$0.13 | -$0.22 | 40.91% |
| 2013-06-30 | 2013-08-02 | $3.83 million | -$0.26 | -$0.29 | 10.34% |
| 2013-03-31 | 2013-04-26 | $25 million | -$0.02 | -$0.15 | 86.67% |
| 2012-12-31 | 2013-01-25 | $2.61 million | -$0.29 | -$0.25 | -16% |
| 2012-09-30 | 2012-10-26 | $4.09 million | -$0.30 | -$0.25 | -20% |
| 2012-06-30 | 2012-08-03 | $2.95 million | -$0.29 | -$0.30 | 3.33% |
| 2012-03-31 | 2012-04-27 | $3.25 million | -$0.24 | -$0.25 | 4% |
| 2011-12-31 | 2012-01-27 | $7.62 million | -$0.17 | -$0.23 | 26.09% |
| 2011-09-30 | 2011-10-27 | $2.54 million | -$0.26 | -$0.22 | -18.18% |
| 2011-06-30 | 2011-08-03 | $6.51 million | -$0.23 | -$0.24 | 4.17% |
| 2011-03-31 | 2011-04-28 | $5.21 million | -$0.22 | -$0.23 | 4.35% |
| 2010-12-31 | 2011-01-27 | $4.18 million | -$0.21 | -$0.21 | 0% |
| 2010-09-30 | 2010-10-28 | $3.41 million | -$0.19 | -$0.23 | 17.39% |
| 2010-06-30 | 2010-08-04 | $4.42 million | -$0.21 | -$0.24 | 12.5% |
| 2010-03-31 | 2010-04-29 | $3.31 million | -$0.21 | -$0.23 | 8.7% |
| 2009-12-31 | 2010-01-28 | $3.11 million | -$0.23 | -$0.21 | -9.52% |
| 2009-09-30 | 2009-10-29 | $3.1 million | -$0.22 | -$0.20 | -10% |
| 2009-06-30 | 2009-08-06 | $4.3 million | -$0.21 | -$0.17 | -23.53% |
| 2009-03-31 | 2009-04-30 | $8.23 million | -$0.09 | -$0.09 | 0% |
| 2008-12-31 | 2009-01-29 | $9.33 million | -$0.14 | -$0.15 | 6.67% |
| 2008-09-30 | 2008-10-27 | $6.13 million | -$0.19 | -$0.20 | 5% |
| 2008-06-30 | 2008-08-07 | $4.48 million | -$0.27 | -$0.24 | -12.5% |
| 2008-03-31 | 2008-05-01 | $14.59 million | -$0.30 | -$0.22 | -36.36% |
| 2007-12-31 | 2008-01-31 | $9.75 million | -$0.15 | -$0.15 | 0% |
| 2007-09-30 | 2007-11-01 | $11.43 million | -$0.02 | -$0.10 | 80% |
| 2007-06-30 | 2007-08-09 | $8.53 million | -$0.11 | -$0.11 | 0% |
| 2007-03-31 | 2007-05-03 | $9.84 million | -$0.12 | -$0.14 | 14.29% |
| 2006-12-31 | 2007-02-01 | $12.07 million | -$0.07 | -$0.13 | 46.15% |
| 2006-09-30 | 2006-11-02 | $7.77 million | -$0.15 | -$0.17 | 11.76% |
| 2006-06-30 | 2006-08-10 | $8.37 million | -$0.16 | -$0.13 | -23.08% |
| 2006-03-31 | 2006-05-04 | $9.36 million | -$0.07 | -$0.07 | 0% |
| 2005-12-31 | 2006-02-02 | $6.59 million | -$0.09 | -$0.12 | 25% |
| 2005-09-30 | 2005-11-03 | $7.78 million | -$0.11 | -$0.09 | -22.22% |
| 2005-06-30 | 2005-08-11 | $7.43 million | -$0.07 | -$0.11 | 36.36% |
| 2005-03-31 | 2005-05-05 | $10.23 million | -$0.09 | -$0.08 | -12.5% |
| 2004-12-31 | 2005-02-03 | $9.05 million | -$0.05 | -$0.08 | 37.5% |
| 2004-09-30 | 2004-11-04 | $9.01 million | -$0.06 | -$0.07 | 14.29% |
| 2004-06-30 | 2004-08-12 | $9.31 million | $0.01 | -$0.10 | 110% |
| 2004-03-31 | 2004-05-13 | $7.59 million | -$0.02 | -$0.07 | 71.43% |
| 2003-12-31 | 2004-02-12 | $5.16 million | -$0.03 | -$0.07 | 57.14% |
| 2003-09-30 | 2003-11-06 | $3.89 million | -$0.10 | -$0.08 | -25% |
| 2003-06-30 | 2003-08-07 | $1.35 million | -$0.17 | -$0.14 | -21.43% |
| 2003-03-31 | 2003-05-08 | $1.46 million | -$0.11 | -$0.12 | 8.33% |
| 2002-12-31 | 2003-02-06 | $2.48 million | -$0.12 | -$0.09 | -33.33% |
| 2002-09-30 | 2002-11-07 | $2.35 million | -$0.08 | -$0.11 | 27.27% |
| 2002-06-30 | 2002-08-08 | $1.7 million | -$0.11 | -$0.14 | 21.43% |
| 2002-03-31 | 2002-05-09 | $1.21 million | -$0.17 | -$0.08 | -112.5% |
| 2001-12-31 | 2002-02-07 | $1.54 million | -$0.04 | -$0.05 | 20% |
| 2001-09-30 | 2001-11-08 | $1.43 million | -$0.04 | -$0.04 | 0% |
| 2001-06-30 | 2001-08-16 | $525000 | -$0.09 | -$0.05 | -80% |
| 2001-03-31 | 2001-05-11 | $1.03 million | -$0.05 | -$0.05 | 0% |
| 2000-12-31 | 2001-02-08 | $715000 | -$0.07 | $0.06 | -216.67% |
| 2000-09-30 | 2000-10-26 | $2.21 million | -$0.07 | $0.01 | -800% |
| 2000-06-30 | 2000-06-30 | $4.68 million | $0.02 | ||
| 2000-03-31 | 2000-03-31 | $N/A | -$0.09 | ||
| 1999-12-31 | 1999-12-31 | $0.00 | |||
| 1999-09-30 | 1999-09-30 | $0.05 | |||
| 1999-03-31 | 1999-03-31 | -$0.03 | |||
| 1998-12-31 | 1998-12-31 | -$0.06 | |||
| 1998-09-30 | 1998-09-30 | -$0.10 | |||
| 1995-06-30 | 1995-09-07 | -$0.32 | -$0.31 | -3.23% | |
| 1995-03-31 | 1995-05-01 | -$0.34 | -$0.33 | -3.03% | |
| 1994-12-31 | 1995-01-19 | -$0.48 | -$0.44 | -9.09% | |
| 1994-09-30 | 1994-10-20 | -$0.44 | -$0.46 | 4.35% | |
| 1994-06-30 | 1994-08-18 | -$0.52 | -$0.40 | -30% | |
| 1994-03-31 | 1994-04-29 | -$0.51 | -$0.49 | -4.08% | |
| 1993-12-31 | 1994-02-11 | -$0.59 | -$0.51 | -15.69% | |
| 1993-09-30 | 1993-10-29 | -$0.46 | -$0.49 | 6.12% | |
| 1993-06-30 | 1993-08-27 | -$0.50 | -$0.45 | -11.11% | |
| 1993-03-31 | 1993-04-27 | -$0.43 | -$0.45 | 4.44% | |
| 1992-12-31 | 1993-02-10 | -$0.47 | -$0.34 | -38.24% |
ImmunoGen, Inc (IMGN) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
ImmunoGen, Inc (IMGN) Chart:
ImmunoGen, Inc (IMGN) News:
Below you will find a list of latest news for ImmunoGen, Inc (IMGN) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
ImmunoGen, Inc (IMGN) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-19 | 3 | 25 | CALL | 1 | 1 | 85.37 | TRUE | 0 | 0 |
| 2025-12-19 | 5 | 0 | CALL | 0 | 0 | 157.4 | TRUE | 0 | 0 |
| 2025-12-19 | 8 | 19.6 | CALL | 10 | 11 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 10 | 19.5 | CALL | 3 | 15 | 87.43 | TRUE | 0 | 0 |
| 2025-12-19 | 12 | 10.88 | CALL | 1 | 4 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 15 | 15 | CALL | 2 | 82 | 50.66 | TRUE | 0 | 0 |
| 2025-12-19 | 17 | 12.5 | CALL | 3 | 5 | 44.62 | TRUE | 0 | 0 |
| 2025-12-19 | 20 | 11.2 | CALL | 0 | 23 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 22 | 9 | CALL | 10 | 20 | 24.83 | TRUE | 0 | 0 |
| 2025-12-19 | 25 | 6.2 | CALL | 0 | 399 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 27 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 30 | 1.3 | CALL | 0 | 110 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 32 | 0.05 | CALL | 0 | 307 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 35 | 0.15 | CALL | 0 | 56 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 37 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 40 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 42 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 3 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 5 | 0.05 | PUT | 2 | 2 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 8 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 10 | 2.1 | PUT | 5 | 5 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 12 | 4.2 | PUT | 1 | 0 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 15 | 0.25 | PUT | 1 | 1 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 17 | 0.25 | PUT | 1 | 6 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 20 | 0.6 | PUT | 0 | 110 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 22 | 0.5 | PUT | 0 | 7 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 25 | 0.25 | PUT | 0 | 7 | 16.48 | FALSE | 0 | 0 |
| 2025-12-19 | 27 | 0.04 | PUT | 0 | 12 | 8.8 | FALSE | 0 | 0 |
| 2025-12-19 | 30 | 0.05 | PUT | 0 | 47 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 32 | 2 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 35 | 5 | PUT | 0 | 0 | 22.51 | TRUE | 0 | 0 |
| 2025-12-19 | 37 | 0 | PUT | 0 | 0 | 22.67 | TRUE | 0 | 0 |
| 2025-12-19 | 40 | 8 | PUT | 0 | 10 | 32.07 | TRUE | 0 | 0 |
| 2025-12-19 | 42 | 0 | PUT | 0 | 0 | 28.55 | TRUE | 0 | 0 |
| 2026-01-16 | 3 | 0 | CALL | 0 | 0 | 97.6 | TRUE | 0 | 0 |
| 2026-01-16 | 5 | 0 | CALL | 0 | 0 | 153.96 | TRUE | 0 | 0 |
| 2026-01-16 | 8 | 9.35 | CALL | 0 | 10 | 104.83 | TRUE | 0 | 0 |
| 2026-01-16 | 10 | 0 | CALL | 0 | 0 | 85.18 | TRUE | 0 | 0 |
| 2026-01-16 | 13 | 7 | CALL | 10 | 10 | 63.74 | TRUE | 0 | 0 |
| 2026-01-16 | 15 | 15 | CALL | 5 | 20 | 52.56 | TRUE | 0 | 0 |
| 2026-01-16 | 17 | 13.25 | CALL | 3 | 103 | 37.31 | TRUE | 0 | 0 |
| 2026-01-16 | 20 | 10.3 | CALL | 0 | 20 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 22 | 9.1 | CALL | 55 | 178 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 25 | 6.32 | CALL | 750 | 2031 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 27 | 4.24 | CALL | 0 | 538 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 30 | 1.3 | CALL | 0 | 176 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 32 | 0.05 | CALL | 0 | 1015 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 35 | 0.05 | CALL | 0 | 247 | 1.44 | FALSE | 0 | 0 |
| 2026-01-16 | 37 | 0.2 | CALL | 1 | 1 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 40 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 42 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 3 | 0.05 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 5 | 0.2 | PUT | 1 | 2 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 8 | 0.1 | PUT | 5 | 8 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 10 | 0.05 | PUT | 0 | 20 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 13 | 0.05 | PUT | 0 | 213 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 15 | 0.05 | PUT | 0 | 186 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 17 | 0.05 | PUT | 0 | 61 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 20 | 0.3 | PUT | 1 | 226 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 22 | 0.05 | PUT | 0 | 76 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 25 | 0.05 | PUT | 0 | 127 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 27 | 0.5 | PUT | 2 | 51 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 30 | 0.05 | PUT | 0 | 169 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 32 | 0 | PUT | 0 | 0 | 8.13 | TRUE | 0 | 0 |
| 2026-01-16 | 35 | 0 | PUT | 0 | 0 | 15.63 | TRUE | 0 | 0 |
| 2026-01-16 | 37 | 0 | PUT | 0 | 0 | 21.25 | TRUE | 0 | 0 |
| 2026-01-16 | 40 | 0 | PUT | 0 | 0 | 28.02 | TRUE | 0 | 0 |
| 2026-01-16 | 42 | 0 | PUT | 0 | 0 | 33.77 | TRUE | 0 | 0 |
Latest IMGN Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 30 | $3.17 |
| Jun 13, 2022 7:59 PM EST | 100 | $3.165 |
| Jun 13, 2022 7:59 PM EST | 5 | $3.17 |
| Jun 13, 2022 7:59 PM EST | 100 | $3.165 |
| Jun 13, 2022 7:59 PM EST | 100 | $3.165 |
ImmunoGen, Inc (IMGN) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837020007992/0001558370-20-007992-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000009375119000221/0000093751-19-000221-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000009375120000462/0000093751-20-000462-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000021545719004093/0000215457-19-004093-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000083423720005400/0000834237-20-005400-index.htm |
| 2019-01-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000089542119000016/0000895421-19-000016-index.htm |
| 2019-05-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000089542119000464/0000895421-19-000464-index.htm |
| 2020-02-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000090221920000355/0000902219-20-000355-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000093247119005947/0000932471-19-005947-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000103738920000068/0001037389-20-000068-index.htm |
| 2020-01-22 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/855654/000104746920000389/0001047469-20-000389-index.htm |
| 2020-01-23 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/855654/000104746920000445/0001047469-20-000445-index.htm |
| 2018-11-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000110465918065577/0001104659-18-065577-index.htm |
| 2018-11-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000110465918069896/0001104659-18-069896-index.htm |
| 2019-02-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000110465919006516/0001104659-19-006516-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000110465919052439/0001104659-19-052439-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000110465919052440/0001104659-19-052440-index.htm |
| 2019-12-20 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/855654/000110465919074862/0001104659-19-074862-index.htm |
| 2019-12-20 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/855654/000110465919074866/0001104659-19-074866-index.htm |
| 2019-12-20 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/855654/000110465919074868/0001104659-19-074868-index.htm |
| 2019-12-20 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/855654/000110465919074869/0001104659-19-074869-index.htm |
| 2019-12-20 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/855654/000110465919074870/0001104659-19-074870-index.htm |
| 2019-12-20 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/855654/000110465919074871/0001104659-19-074871-index.htm |
| 2020-01-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000110465920005920/0001104659-20-005920-index.htm |
| 2020-01-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000110465920006298/0001104659-20-006298-index.htm |
| 2020-01-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000110465920007129/0001104659-20-007129-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000110465920017714/0001104659-20-017714-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000110465920021821/0001104659-20-021821-index.htm |
| 2020-09-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/855654/000110465920108918/0001104659-20-108918-index.htm |
| 2020-09-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000110465920108942/0001104659-20-108942-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000114420419008081/0001144204-19-008081-index.htm |
| 2018-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911018011756/0001179110-18-011756-index.htm |
| 2018-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911018011757/0001179110-18-011757-index.htm |
| 2018-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911018012212/0001179110-18-012212-index.htm |
| 2018-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911018012629/0001179110-18-012629-index.htm |
| 2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019000025/0001179110-19-000025-index.htm |
| 2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019000026/0001179110-19-000026-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019000356/0001179110-19-000356-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019000357/0001179110-19-000357-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019000358/0001179110-19-000358-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019000359/0001179110-19-000359-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019000360/0001179110-19-000360-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019000361/0001179110-19-000361-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019000546/0001179110-19-000546-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019001226/0001179110-19-001226-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019001227/0001179110-19-001227-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019001228/0001179110-19-001228-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019001229/0001179110-19-001229-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019001230/0001179110-19-001230-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019001231/0001179110-19-001231-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019001232/0001179110-19-001232-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019001233/0001179110-19-001233-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019001405/0001179110-19-001405-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019002466/0001179110-19-002466-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019002467/0001179110-19-002467-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019002468/0001179110-19-002468-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019002469/0001179110-19-002469-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019002470/0001179110-19-002470-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019002471/0001179110-19-002471-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019004395/0001179110-19-004395-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019004396/0001179110-19-004396-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019004809/0001179110-19-004809-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008039/0001179110-19-008039-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008040/0001179110-19-008040-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008041/0001179110-19-008041-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008042/0001179110-19-008042-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008043/0001179110-19-008043-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008044/0001179110-19-008044-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008223/0001179110-19-008223-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008224/0001179110-19-008224-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008312/0001179110-19-008312-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008313/0001179110-19-008313-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008314/0001179110-19-008314-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008315/0001179110-19-008315-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008316/0001179110-19-008316-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008317/0001179110-19-008317-index.htm |
| 2019-07-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019008745/0001179110-19-008745-index.htm |
| 2019-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911019011975/0001179110-19-011975-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020000001/0001179110-20-000001-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020000002/0001179110-20-000002-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020000180/0001179110-20-000180-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020000181/0001179110-20-000181-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020001425/0001179110-20-001425-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020001426/0001179110-20-001426-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020001427/0001179110-20-001427-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020001428/0001179110-20-001428-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020001429/0001179110-20-001429-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020002183/0001179110-20-002183-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020002184/0001179110-20-002184-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020002185/0001179110-20-002185-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020002186/0001179110-20-002186-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020002187/0001179110-20-002187-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020004404/0001179110-20-004404-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020004405/0001179110-20-004405-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020004487/0001179110-20-004487-index.htm |
| 2020-06-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020006965/0001179110-20-006965-index.htm |
| 2020-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020006966/0001179110-20-006966-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020007527/0001179110-20-007527-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020007528/0001179110-20-007528-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020007530/0001179110-20-007530-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020007531/0001179110-20-007531-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020007532/0001179110-20-007532-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020007533/0001179110-20-007533-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020007815/0001179110-20-007815-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020007816/0001179110-20-007816-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020007817/0001179110-20-007817-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020007818/0001179110-20-007818-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020007819/0001179110-20-007819-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020007820/0001179110-20-007820-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020007821/0001179110-20-007821-index.htm |
| 2020-07-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020008406/0001179110-20-008406-index.htm |
| 2020-07-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020008407/0001179110-20-008407-index.htm |
| 2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020010029/0001179110-20-010029-index.htm |
| 2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/855654/000117911020010030/0001179110-20-010030-index.htm |
| 2018-11-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/855654/000155837018008331/0001558370-18-008331-index.htm |
| 2019-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019000097/0001558370-19-000097-index.htm |
| 2019-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019000099/0001558370-19-000099-index.htm |
| 2019-01-08 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019000106/0001558370-19-000106-index.htm |
| 2019-03-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019001386/0001558370-19-001386-index.htm |
| 2019-03-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/855654/000155837019001432/0001558370-19-001432-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/855654/000155837019003565/0001558370-19-003565-index.htm |
| 2019-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/855654/000155837019003567/0001558370-19-003567-index.htm |
| 2019-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019003907/0001558370-19-003907-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/855654/000155837019004233/0001558370-19-004233-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019005036/0001558370-19-005036-index.htm |
| 2019-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019005854/0001558370-19-005854-index.htm |
| 2019-06-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019005919/0001558370-19-005919-index.htm |
| 2019-08-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019006872/0001558370-19-006872-index.htm |
| 2019-08-02 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019006899/0001558370-19-006899-index.htm |
| 2019-08-05 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019007024/0001558370-19-007024-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/855654/000155837019007500/0001558370-19-007500-index.htm |
| 2019-09-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019008729/0001558370-19-008729-index.htm |
| 2019-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019009627/0001558370-19-009627-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/855654/000155837019010010/0001558370-19-010010-index.htm |
| 2019-11-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019011219/0001558370-19-011219-index.htm |
| 2019-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019011539/0001558370-19-011539-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837019011637/0001558370-19-011637-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837020000126/0001558370-20-000126-index.htm |
| 2020-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837020000801/0001558370-20-000801-index.htm |
| 2020-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837020000846/0001558370-20-000846-index.htm |
| 2020-03-11 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/855654/000155837020002399/0001558370-20-002399-index.htm |
| 2020-04-17 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/855654/000155837020003993/0001558370-20-003993-index.htm |
| 2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/855654/000155837020004448/0001558370-20-004448-index.htm |
| 2020-04-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/855654/000155837020004450/0001558370-20-004450-index.htm |
| 2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837020004868/0001558370-20-004868-index.htm |
| 2020-05-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/855654/000155837020005161/0001558370-20-005161-index.htm |
| 2020-06-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/855654/000155837020007213/0001558370-20-007213-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837020007590/0001558370-20-007590-index.htm |
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837020007992/0001558370-20-007992-index.htm |
| 2020-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837020008296/0001558370-20-008296-index.htm |
| 2020-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837020008826/0001558370-20-008826-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/855654/000155837020009337/0001558370-20-009337-index.htm |
| 2020-10-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837020011447/0001558370-20-011447-index.htm |
| 2020-10-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837020011540/0001558370-20-011540-index.htm |
| 2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837020011716/0001558370-20-011716-index.htm |
| 2020-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/855654/000155837020013010/0001558370-20-013010-index.htm |
| 2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/855654/000155837020013027/0001558370-20-013027-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000156761919004267/0001567619-19-004267-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/855654/000156761920003753/0001567619-20-003753-index.htm |
| 2019-03-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/855654/999999999719001397/9999999997-19-001397-index.htm |
| 2019-03-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/855654/999999999719001425/9999999997-19-001425-index.htm |
| 2019-12-06 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/855654/999999999719007777/9999999997-19-007777-index.htm |
| 2019-12-06 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/855654/999999999719007778/9999999997-19-007778-index.htm |
| 2020-04-30 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/855654/999999999720002338/9999999997-20-002338-index.htm |
ImmunoGen, Inc (IMGN) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ImmunoGen, Inc (IMGN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 54%Institutional Ownership: 7363%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | Anna Berkenblit | VP & Chief Medical Officer | Buy | 3,047.00 | 3.91 | 11,913.77 | 101,136.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020007818/0001179110-20-007818-index.htm |
| 2018-02-22 | Anna Berkenblit | VP & Chief Medical Officer | Sell | 16,562.00 | 5.60 | 92,747.20 | 118,662.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019002468/0001179110-19-002468-index.htm |
| 2019-07-01 | Anna Berkenblit | VP & Chief Medical Officer | Buy | 5,230.00 | 1.84 | 9,623.20 | 123,892.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019008317/0001179110-19-008317-index.htm |
| 2018-10-16 | Anna Berkenblit | VP & Chief Medical Officer | Sell | 5,851.00 | 8.00 | 46,808.00 | 132,769.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911018012212/0001179110-18-012212-index.htm |
| 2019-01-03 | Anna Berkenblit | VP & Chief Medical Officer | Buy | 2,455.00 | 4.08 | 10,016.40 | 135,224.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019000356/0001179110-19-000356-index.htm |
| 2020-02-24 | CRAIG BARROWS | Executive VP, General Counsel | Sell | 16,492.00 | 4.99 | 82,295.08 | 145,275.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020002183/0001179110-20-002183-index.htm |
| 2018-02-22 | CRAIG BARROWS | Executive VP, General Counsel | Sell | 14,870.00 | 5.60 | 83,272.00 | 156,537.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019002467/0001179110-19-002467-index.htm |
| 2019-07-01 | CRAIG BARROWS | Executive VP, General Counsel | Buy | 5,230.00 | 1.84 | 9,623.20 | 161,767.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019008312/0001179110-19-008312-index.htm |
| 2019-01-03 | CRAIG BARROWS | Executive VP, General Counsel | Buy | 2,455.00 | 4.08 | 10,016.40 | 171,407.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019000361/0001179110-19-000361-index.htm |
| 2018-02-22 | Richard J. Gregory | Executive VP & CSO | Sell | 36,643.00 | 5.60 | 205,200.80 | 199,413.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019002466/0001179110-19-002466-index.htm |
| 2020-04-02 | DAVID G FOSTER | V.P.-Fin., Prin. Acctg. Off. | Sell | 5,448.00 | 3.43 | 18,686.64 | 21,382.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020004487/0001179110-20-004487-index.htm |
| 2020-07-01 | DAVID G FOSTER | V.P.-Fin., Prin. Acctg. Off. | Buy | 342.00 | 3.91 | 1,337.22 | 21,724.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020007820/0001179110-20-007820-index.htm |
| 2019-01-07 | Richard J. Gregory | Executive VP & CSO | Sell | 3,038.00 | 5.27 | 16,013.91 | 236,056.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019000546/0001179110-19-000546-index.htm |
| 2020-04-01 | DAVID G FOSTER | V.P.-Fin., Prin. Acctg. Off. | Buy | 18,160.00 | 26,830.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020004487/0001179110-20-004487-index.htm | ||
| 2019-01-03 | DAVID G FOSTER | V.P.-Fin., Prin. Acctg. Off. | Buy | 1,472.00 | 4.08 | 6,005.76 | 3,472.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019000359/0001179110-19-000359-index.htm |
| 2020-02-24 | Mark J Enyedy | Chief Executive Officer | Sell | 55,222.00 | 4.99 | 275,557.78 | 433,776.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020002186/0001179110-20-002186-index.htm |
| 2020-06-30 | Mark J Enyedy | Chief Executive Officer | Buy | 5,241.00 | 3.91 | 20,492.31 | 439,017.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020007819/0001179110-20-007819-index.htm |
| 2018-02-22 | Mark J Enyedy | Chief Executive Officer | Sell | 51,070.00 | 5.60 | 285,992.00 | 483,768.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019002471/0001179110-19-002471-index.htm |
| 2019-07-01 | Mark J Enyedy | Chief Executive Officer | Buy | 5,230.00 | 1.84 | 9,623.20 | 488,998.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019008316/0001179110-19-008316-index.htm |
| 2019-07-01 | Blaine H. McKee | EVP & Chief Business Officer | Buy | 5,230.00 | 1.84 | 9,623.20 | 5,230.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019008313/0001179110-19-008313-index.htm |
| 2019-01-03 | Mark J Enyedy | Chief Executive Officer | Buy | 2,455.00 | 4.08 | 10,016.40 | 534,838.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019000357/0001179110-19-000357-index.htm |
| 2018-11-06 | Mark Alan Goldberg | Director | Buy | 30,000.00 | 5.76 | 172,800.00 | 53,800.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911018012629/0001179110-18-012629-index.htm |
| 2020-02-24 | Theresa Wingrove | SVP of Regulatory Affairs | Sell | 16,147.00 | 4.99 | 80,573.53 | 70,498.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020002184/0001179110-20-002184-index.htm |
| 2020-06-30 | Theresa Wingrove | VP of Regulatory Affairs | Buy | 2,593.00 | 3.91 | 10,138.63 | 73,091.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020007821/0001179110-20-007821-index.htm |
| 2020-02-24 | Thomas Ryll | SVP, Technical Operations | Sell | 16,790.00 | 4.99 | 83,782.10 | 75,624.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020002187/0001179110-20-002187-index.htm |
| 2019-07-01 | DAVID G FOSTER | V.P.-Fin., Prin. Acctg. Off. | Buy | 3,536.00 | 1.84 | 6,506.24 | 8,008.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019008314/0001179110-19-008314-index.htm |
| 2020-06-30 | Thomas Ryll | VP, Technical Operations | Buy | 5,241.00 | 3.91 | 20,492.31 | 80,865.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020007817/0001179110-20-007817-index.htm |
| 2018-02-22 | Theresa Wingrove | VP of Regulatory Affairs | Sell | 11,032.00 | 5.60 | 61,779.20 | 81,883.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019002469/0001179110-19-002469-index.htm |
| 2019-12-31 | Theresa Wingrove | VP of Regulatory Affairs | Buy | 4,762.00 | 1.99 | 9,476.38 | 86,645.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020000180/0001179110-20-000180-index.htm |
| 2019-12-31 | DAVID G FOSTER | V.P.-Fin., Prin. Acctg. Off. | Buy | 662.00 | 1.99 | 1,317.38 | 8,670.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020000181/0001179110-20-000181-index.htm |
| 2018-02-22 | Thomas Ryll | VP, Technical Operations | Sell | 11,495.00 | 5.60 | 64,372.00 | 87,184.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019002470/0001179110-19-002470-index.htm |
| 2019-07-01 | Thomas Ryll | VP, Technical Operations | Buy | 5,230.00 | 1.84 | 9,623.20 | 92,414.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019008315/0001179110-19-008315-index.htm |
| 2019-01-03 | Theresa Wingrove | VP of Regulatory Affairs | Buy | 2,244.00 | 4.08 | 9,155.52 | 92,915.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019000360/0001179110-19-000360-index.htm |
| 2020-02-24 | Anna Berkenblit | SVP & Chief Medical Officer | Sell | 25,803.00 | 4.99 | 128,756.97 | 98,089.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911020002185/0001179110-20-002185-index.htm |
| 2019-01-03 | Thomas Ryll | VP, Technical Operations | Buy | 2,455.00 | 4.08 | 10,016.40 | 98,679.00 | https://www.sec.gov/Archives/edgar/data/855654/000117911019000358/0001179110-19-000358-index.htm |